Ladenburg Thalmann Financial Services’s Loxo Oncology, Inc LOXO Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-452	Closed	-$64K	–	5500
2018 Q4	$64K	Buy	452 +240	+113%	+$36.4K	﹤0.01%	3091
2018 Q3	$36K	Buy	212 +105	+98%	+$17.6K	﹤0.01%	3539
2018 Q2	$12K	Hold	107	–	–	﹤0.01%	4165
2018 Q1	$12K	Buy	107 +87	+435%	+$9.25K	﹤0.01%	4165
2017 Q4	$2K	Hold	20	–	–	﹤0.01%	4844
2017 Q3	$2K	Buy	+20	New	+$1.55K	﹤0.01%	4735

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Ladenburg Thalmann Financial Services's LOXO Position: Q1 2019 in Review

Ladenburg Thalmann Financial Services sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 452 shares — an estimated $64K sold.

Ladenburg Thalmann Financial Services first reported a position in LOXO in Q3 2017 and held it in 6 quarters. The position peaked at $64K in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Ladenburg Thalmann Financial Services reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 452 Loxo Oncology, Inc shares in Q1 2019, an estimated $64K.
Ladenburg Thalmann Financial Services first reported a position in Loxo Oncology, Inc in Q3 2017 and held it in 6 quarters.
Ladenburg Thalmann Financial Services's Loxo Oncology, Inc position peaked at $64K in Q4 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q1 2019, filed 15 May 2019.